These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32301649)
1. The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis. Brown L; Vranjkovic O; Li J; Yu K; Al Habbab T; Johnson H; Brown K; Jablonski MR; Dechairo B Pharmacogenomics; 2020 Jun; 21(8):559-569. PubMed ID: 32301649 [No Abstract] [Full Text] [Related]
2. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies. Rosenblat JD; Lee Y; McIntyre RS J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459 [TBL] [Abstract][Full Text] [Related]
3. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis. Rosenblat JD; Lee Y; McIntyre RS J Affect Disord; 2018 Dec; 241():484-491. PubMed ID: 30149336 [TBL] [Abstract][Full Text] [Related]
4. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test. Health Quality Ontario Ont Health Technol Assess Ser; 2017; 17(4):1-39. PubMed ID: 28515818 [TBL] [Abstract][Full Text] [Related]